Systemic Lupus Erythematosus Clinical Trials in Oklahoma City, Oklahoma

12 recruitingOklahoma City, Oklahoma

Showing 112 of 12 trials

Recruiting

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Systemic Lupus Erythematosus (SLE)
Bristol-Myers Squibb223 enrolled64 locationsNCT07175285
Recruiting
Phase 2

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus
Boehringer Ingelheim405 enrolled139 locationsNCT07409181
Recruiting
Phase 3

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
AstraZeneca245 enrolled79 locationsNCT07430306
Recruiting
Phase 1

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Lupus Nephritis+2 more
Fate Therapeutics244 enrolled21 locationsNCT06308978
Recruiting
Phase 1

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

Systemic Lupus Erythematosus
GlaxoSmithKline142 enrolled27 locationsNCT06576271
Recruiting

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

Systemic Lupus ErythematosusAntiphospholipid Syndrome
Hospital for Special Surgery, New York700 enrolled10 locationsNCT00198068
Recruiting
Phase 4

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

Systemic Lupus Erythematosus (SLE)Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
Bristol-Myers Squibb35 enrolled4 locationsNCT06875960
Recruiting
Phase 3

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
AbbVie1,000 enrolled369 locationsNCT05843643
Recruiting
Phase 3

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

Systemic Lupus Erythematosus
NYU Langone Health330 enrolled10 locationsNCT05799378
Recruiting
Phase 4

Safety of the Herpes Zoster Subunit Vaccine in Lupus

Systemic Lupus Erythematosus
NYU Langone Health224 enrolled2 locationsNCT05559671
Recruiting
Phase 2

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Zenas BioPharma (USA), LLC190 enrolled82 locationsNCT06559163
Recruiting
Phase 2

Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine

Systemic Lupus Erythematosus
State University of New York - Upstate Medical University290 enrolled8 locationsNCT00775476